X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1377) 1377
Publication (113) 113
Book Review (16) 16
Book Chapter (7) 7
Dissertation (3) 3
Magazine Article (2) 2
Paper (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (833) 833
humans (790) 790
index medicus (682) 682
animals (637) 637
female (504) 504
rats (346) 346
middle aged (300) 300
pharmacology & pharmacy (269) 269
adrenergic beta-antagonists - pharmacology (267) 267
heart rate - drug effects (242) 242
adult (241) 241
adrenergic beta-1 receptor antagonists - administration & dosage (235) 235
cardiac & cardiovascular systems (224) 224
aged (205) 205
dose-response relationship, drug (197) 197
blood pressure - drug effects (196) 196
adrenergic beta-antagonists - therapeutic use (186) 186
treatment outcome (183) 183
receptors, adrenergic, beta-1 - metabolism (151) 151
heart failure (147) 147
adrenergic beta-1 receptor antagonists - pharmacology (144) 144
adrenergic beta-1 receptor antagonists - therapeutic use (139) 139
hypertension (131) 131
adrenergic beta-1 receptor antagonists (130) 130
metoprolol (125) 125
neurosciences (124) 124
heart failure - drug therapy (123) 123
propanolamines - pharmacology (123) 123
adrenergic beta-antagonists - administration & dosage (122) 122
rats, sprague-dawley (120) 120
propanolamines - administration & dosage (115) 115
rats, wistar (112) 112
time factors (108) 108
hypertension - drug therapy (103) 103
mice (99) 99
isoproterenol - pharmacology (97) 97
metoprolol - administration & dosage (95) 95
propranolol - pharmacology (95) 95
adrenergic beta-agonists - pharmacology (93) 93
medicine & public health (92) 92
receptors, adrenergic, beta-1 - drug effects (91) 91
receptors, adrenergic, beta-1 - genetics (91) 91
mortality (87) 87
atenolol (86) 86
heart rate (85) 85
propanolamines - therapeutic use (84) 84
hemodynamics - drug effects (82) 82
nebivolol (82) 82
abridged index medicus (81) 81
beta-blockers (80) 80
care and treatment (80) 80
metoprolol - pharmacology (80) 80
propranolol (80) 80
double-blind method (79) 79
heart (79) 79
analysis (78) 78
drug therapy (77) 77
adrenergic receptors (76) 76
cardiology (76) 76
atenolol - pharmacology (75) 75
cardiovascular (75) 75
disease models, animal (75) 75
receptors, adrenergic, beta-2 - metabolism (75) 75
carvedilol (74) 74
prospective studies (73) 73
receptors, adrenergic, beta - drug effects (71) 71
blood pressure (70) 70
heart failure - physiopathology (69) 69
metoprolol - therapeutic use (69) 69
norepinephrine (68) 68
esmolol (67) 67
in vitro techniques (66) 66
beta-blocker (65) 65
research (65) 65
young adult (65) 65
surgery (64) 64
adrenergic beta-1 receptor antagonists - adverse effects (63) 63
dosage and administration (62) 62
electrocardiography (61) 61
risk factors (61) 61
drug therapy, combination (60) 60
myocardium - metabolism (59) 59
physiology (59) 59
administration, oral (58) 58
heart - drug effects (58) 58
receptors, adrenergic, beta-1 - physiology (58) 58
norepinephrine - pharmacology (57) 57
article (56) 56
hypertension - physiopathology (56) 56
receptors (56) 56
therapy (56) 56
dogs (54) 54
health aspects (54) 54
heart beat (54) 54
heart-failure (54) 54
rodents (54) 54
adrenergic beta-antagonists - adverse effects (53) 53
peripheral vascular disease (53) 53
aged, 80 and over (52) 52
adolescent (51) 51
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1354) 1354
Russian (19) 19
German (5) 5
Japanese (3) 3
Chinese (1) 1
French (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 03/2018, Volume 78, Issue 3, pp. 377 - 388
Intravenous landiolol [Rapibloc (R) (EU)], an ultra short-acting highly cardioselective beta(1)-blocker, is approved in the EU for the rapid short-term control... 
TRACHEAL INTUBATION | LEFT-VENTRICULAR DYSFUNCTION | LOW-DOSE LANDIOLOL | PHARMACOLOGY & PHARMACY | POSTOPERATIVE ATRIAL-FIBRILLATION | ACTING BETA-BLOCKER | DECOMPENSATED HEART-FAILURE | SUPRAVENTRICULAR TACHYARRHYTHMIAS | TOXICOLOGY | BETA-1-SELECTIVE BLOCKER | RAPID ATRIAL | BISPECTRAL INDEX | Adrenergic beta-1 Receptor Antagonists - adverse effects | Tachycardia, Supraventricular - drug therapy | Humans | Adrenergic beta-1 Receptor Antagonists - pharmacology | Drug Approval | Adrenergic beta-1 Receptor Antagonists - therapeutic use | Dose-Response Relationship, Drug | Heart Rate - drug effects | Urea - analogs & derivatives | Adrenergic beta-1 Receptor Antagonists - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Tachycardia - drug therapy | Urea - administration & dosage | Atrial Fibrillation - drug therapy | Japan | Morpholines - administration & dosage | Morpholines - pharmacology | Treatment Outcome | Heart Failure - drug therapy | Administration, Intravenous | Urea - therapeutic use | Ventricular Dysfunction, Left - drug therapy | Urea - adverse effects | Urea - pharmacology | Short term | Cardiac arrhythmia | Intensive care | Intravenous administration | Digoxin | Heart surgery | Weaning | Clinical trials | Powder | Sinuses | Fibrillation | Electrocardiography | Flutter | Blood pressure | Formulations | Medical research | Electroconvulsive therapy | Pharmacology | Diltiazem | Hypotension | Heart rate | Studies | Tachycardia | Bradycardia | ECS | Comparative studies | Adrenergic receptors | Intubation | Hemodynamics | Cancer
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2014, Volume 135, Issue 2, pp. 491 - 499
Background Cofactors contribute to the elicitation of anaphylaxis. β-Blockers and angiotensin-converting enzyme (ACE) inhibitors are widely used cardiovascular... 
Allergy and Immunology | β-blocker | Anaphylaxis | cardiovascular medication | mast cells | angiotensin-converting enzyme inhibitor | cofactor | BASE-LINE | beta-blocker | RISK-FACTORS | MOUSE | LEUKOTRIENES | HISTAMINE-RELEASE | MECHANISMS | IMMUNOLOGY | MEDIATOR RELEASE | ALLERGY | EXPRESSION | HYPERSENSITIVITY | Adrenergic beta-1 Receptor Antagonists - adverse effects | Humans | Antihypertensive Agents - administration & dosage | Male | Risk | Ramipril - administration & dosage | Dose-Response Relationship, Drug | Immunoglobulin E - immunology | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Histamine Release | Inflammation Mediators - metabolism | Mast Cells - metabolism | Adult | Female | Registries | Adrenergic beta-1 Receptor Antagonists - administration & dosage | Drug Therapy, Combination | Ramipril - adverse effects | Child | Severity of Illness Index | Mast Cells - immunology | Anaphylaxis - etiology | Metoprolol - administration & dosage | Metoprolol - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Mast Cells - drug effects | Antihypertensive Agents - adverse effects | Animals | Anaphylaxis - diagnosis | Anaphylaxis - epidemiology | Mice | Enzymes | Ramipril | Analysis | Angiotensin | Medicine | Medical research | Hospitals | Child development | Dermatology | Colleges & universities | Otolaryngology | Drug therapy | Drug dosages | Allergies | Children & youth
Journal Article
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 8/2011, Volume 37, Issue 8, pp. 1344 - 1351
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0172361
Purpose Crystalloid fluid and vasoactive drugs are used in the early treatment of sepsis. The purpose of the present study was to examine how these drugs alter... 
VOLUME KINETICS | SHOCK | INFUSION | MANAGEMENT | SALINE | MULTIDISCIPLINARY SCIENCES | Norepinephrine - pharmacology | Isotonic Solutions - therapeutic use | Adrenergic beta-1 Receptor Antagonists - pharmacology | Isotonic Solutions - administration & dosage | Norepinephrine - administration & dosage | Male | Adrenergic beta-1 Receptor Antagonists - therapeutic use | Sodium Chloride - therapeutic use | Phenylephrine - administration & dosage | Cardiotonic Agents - therapeutic use | Sepsis - drug therapy | Propanolamines - therapeutic use | Phenylephrine - pharmacology | Ringer's Lactate | Adrenergic beta-1 Receptor Antagonists - administration & dosage | Phenylephrine - therapeutic use | Dopamine - therapeutic use | Vasoconstrictor Agents - pharmacology | Vasoconstrictor Agents - therapeutic use | Norepinephrine - therapeutic use | Vasoconstrictor Agents - administration & dosage | Crystalloid Solutions | Dopamine - pharmacology | Sodium Chloride - administration & dosage | Cardiotonic Agents - pharmacology | Dopamine - administration & dosage | Animals | Cardiotonic Agents - administration & dosage | Sodium Chloride - pharmacokinetics | Sheep | Hemodynamics - drug effects | Sepsis - blood | Isotonic Solutions - pharmacokinetics | Propanolamines - administration & dosage | Propanolamines - pharmacology | Care and treatment | Analysis | Phenylephrine | Sepsis | Dosage and administration | Drug therapy | Blood plasma | Drugs | Stimulation | Tissues | Infusion | Receptors | Vasoactive agents | Hemoglobin | Anesthesia | Blood pressure | Drug dosages | Urine | Edema | Excretion | Stroke | Dopamine | Cecum | Fluid | Pharmacology | Blood levels | Stroke volume | Hospitals | Norepinephrine | Lactic acid | Hemodynamics | Kinetics | Anesthesiology | Acid-base status | Laboratory animals | Acidosis
Journal Article
Journal Article
Resuscitation, ISSN 0300-9572, 2016, Volume 107, pp. 150 - 155
Journal Article